Breaking News Instant updates and real-time market news.

YMAB

Y-mAbs Therapeutics

$25.58

-1.01 (-3.80%)

16:14
09/03/19
09/03
16:14
09/03/19
16:14

Y-mAbs Therapeutics initiated with an Outperform at Wedbush

Wedbush analyst David Nierengarten started Y-mAbs Therapeutics with an Outperform rating and $38 price target.

  • 09

    Sep

YMAB Y-mAbs Therapeutics
$25.58

-1.01 (-3.80%)

10/16/18
ADAM
10/16/18
INITIATION
Target $30
ADAM
Buy
Y-mAbs Therapeutics initiated with a Buy at Canaccord
Canaccord analyst Arlinda Lee initiated Y-mAbs Therapeutics with a Buy rating citing its staggered and deep pipeline including two late stage clinical drug candidates. The analyst sees top-line data from the company's pivotal Study 201 of naxitamab and an initiation of Study 17-251 of naxitamab + chemo in refractory NB in 2018 as near-term catalysts. Lee has a $30 price target on Y-mAbs Therapeutics shares.
10/16/18
COWN
10/16/18
INITIATION
COWN
Outperform
Y-mAbs Therapeutics initiated with an Outperform at Cowen
Cowen analyst Boris Peaker initiated Y-mAbs Therapeutics with an Outperform rating. He noted the company has two pivotal stage drugs for rare pediatric cancers. He believes the assets are highly de-risked and offer high barriers for potential competitors. Peaker has not established a price target yet.
04/01/19
HCWC
04/01/19
INITIATION
Target $36
HCWC
Buy
Y-mAbs Therapeutics initiated with a Buy at H.C. Wainwright
H.C. Wainwright analyst Raghuram Selvaraju started Y-mAbs Therapeutics with a Buy rating and $36 price target. The company has a "highly differentiated business model," focusing on rare, hitherto difficult-to-treat pediatric cancers with next-generation monoclonal antibody therapeutics, Selvaraju tells investors in a research note. He believes the company's is a platform "possesses multiple advantages."
06/10/19
HCWC
06/10/19
NO CHANGE
Target $40
HCWC
Buy
Y-mAbs Therapeutics price target raised to $40 from $36 at H.C. Wainwright
H.C. Wainwright analyst Raghuram Selvaraju raised his price target for Y-mAbs Therapeutics to $40 from $36 saying he's encouraged by omburtamab's efficacy in diffuse intrinsic pontine glioma. Further, he believes the drug's efficacy results may improve in later-stage trials. The analyst reiterates a Buy rating on Y-mAbs.

TODAY'S FREE FLY STORIES

BX

Blackstone

$52.93

-0.57 (-1.07%)

13:30
09/18/19
09/18
13:30
09/18/19
13:30
Periodicals
Blackstone near $2.9B deal to buy Great Wolf Resorts, Bloomberg says »

Privately held…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Sep

  • 26

    Sep

RUBI

Rubicon Project

$9.36

-0.05 (-0.53%)

, TLRA

Telaria

$8.03

-0.195 (-2.37%)

13:26
09/18/19
09/18
13:26
09/18/19
13:26
Recommendations
Rubicon Project, Telaria, Trade Desk analyst commentary  »

Google auction shift…

RUBI

Rubicon Project

$9.36

-0.05 (-0.53%)

TLRA

Telaria

$8.03

-0.195 (-2.37%)

TTD

Trade Desk

$209.29

-3.72 (-1.75%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Sep

  • 24

    Sep

  • 25

    Sep

  • 26

    Sep

  • 30

    Sep

  • 07

    Nov

  • 12

    Nov

FDX

FedEx

$149.76

-23.77 (-13.70%)

13:25
09/18/19
09/18
13:25
09/18/19
13:25
Downgrade
FedEx rating change  »

FedEx downgraded to Hold…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Sep

  • 30

    Sep

  • 01

    Oct

  • 13

    Nov

  • 17

    Dec

13:25
09/18/19
09/18
13:25
09/18/19
13:25
Conference/Events
The SEC to hold a meeting to hear oral arguments »

The Commission will hear…

SOLO

ElectraMeccanica

$2.40

0.04 (1.69%)

13:24
09/18/19
09/18
13:24
09/18/19
13:24
Initiation
ElectraMeccanica initiated  »

ElectraMeccanica…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UN

Unilever; also tag UL

$60.45

0.01 (0.02%)

, PG

Procter & Gamble

$121.47

0.32 (0.26%)

13:23
09/18/19
09/18
13:23
09/18/19
13:23
Recommendations
Unilever; also tag UL, Procter & Gamble, Unilever; also tag UN, Reckitt Benckiser, Henkel, L'Oreal analyst commentary  »

EU Household &…

UN

Unilever; also tag UL

$60.45

0.01 (0.02%)

PG

Procter & Gamble

$121.47

0.32 (0.26%)

UL

Unilever; also tag UN

$61.51

0.05 (0.08%)

RBGLY

Reckitt Benckiser

$0.00

(0.00%)

HENKY

Henkel

$0.00

(0.00%)

LRLCY

L'Oreal

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Oct

  • 08

    Oct

  • 18

    Oct

  • 12

    Nov

NRC

National Research Corporation

$63.59

1.59 (2.56%)

13:23
09/18/19
09/18
13:23
09/18/19
13:23
Hot Stocks
National Research Corporation director Donald Berwick sold over $433K in shares »

National Research…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FB

Facebook

$188.14

0.01 (0.01%)

, TWTR

Twitter

$42.66

-0.59 (-1.36%)

13:22
09/18/19
09/18
13:22
09/18/19
13:22
On The Fly
#SocialStocks: Facebook clarifies oversight structure, Snap in talks to add news »

Welcome to…

FB

Facebook

$188.14

0.01 (0.01%)

TWTR

Twitter

$42.66

-0.59 (-1.36%)

SNAP

Snap

$16.77

-0.1 (-0.59%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Sep

  • 18

    Sep

  • 20

    Sep

  • 24

    Sep

  • 27

    Oct

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

13:17
09/18/19
09/18
13:17
09/18/19
13:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

13:16
09/18/19
09/18
13:16
09/18/19
13:16
Technical Analysis
NYSE market internals summary »

Volume is below average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TYL

Tyler Technologies

$259.19

-0.47 (-0.18%)

13:15
09/18/19
09/18
13:15
09/18/19
13:15
Conference/Events
Tyler Technologies management to meet with Needham »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Sep

  • 25

    Sep

  • 26

    Sep

BRKR

Bruker

$43.21

0.34 (0.79%)

13:14
09/18/19
09/18
13:14
09/18/19
13:14
Conference/Events
Bruker management to meet with Needham »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Sep

  • 24

    Sep

RST

Rosetta Stone

$18.99

-0.22 (-1.15%)

13:13
09/18/19
09/18
13:13
09/18/19
13:13
Conference/Events
Rosetta Stone management to meet with Needham »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Sep

  • 25

    Sep

CYRX

Cryoport

$17.92

0.17 (0.96%)

13:07
09/18/19
09/18
13:07
09/18/19
13:07
Hot Stocks
Breaking Hot Stocks news story on Cryoport »

Cryoport CEO says Seeking…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CYRX

Cryoport

$17.92

0.17 (0.96%)

, GILD

Gilead

$65.78

-0.39 (-0.59%)

13:05
09/18/19
09/18
13:05
09/18/19
13:05
On The Fly
Meet Cryoport: A Fly exclusive interview with CEO Jerry Shelton »

In an exclusive interview…

CYRX

Cryoport

$17.92

0.17 (0.96%)

GILD

Gilead

$65.78

-0.39 (-0.59%)

NVS

Novartis

$86.46

-0.11 (-0.13%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Sep

  • 18

    Sep

  • 19

    Sep

  • 23

    Sep

  • 24

    Sep

  • 25

    Sep

  • 27

    Sep

CYRX

Cryoport

$17.92

0.17 (0.96%)

13:04
09/18/19
09/18
13:04
09/18/19
13:04
Hot Stocks
Breaking Hot Stocks news story on Cryoport »

Shelton sees Cryoport…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CYRX

Cryoport

$17.92

0.17 (0.96%)

13:04
09/18/19
09/18
13:04
09/18/19
13:04
Hot Stocks
Breaking Hot Stocks news story on Cryoport »

Cryoport, Vineti…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CYRX

Cryoport

$17.92

0.17 (0.96%)

, GILD

Gilead

$65.80

-0.37 (-0.56%)

13:04
09/18/19
09/18
13:04
09/18/19
13:04
Hot Stocks
Breaking Hot Stocks news story on Cryoport, Gilead, Novartis »

Gilead, Novartis…

CYRX

Cryoport

$17.92

0.17 (0.96%)

GILD

Gilead

$65.80

-0.37 (-0.56%)

NVS

Novartis

$86.46

-0.11 (-0.13%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Sep

  • 18

    Sep

  • 19

    Sep

  • 23

    Sep

  • 24

    Sep

  • 25

    Sep

  • 27

    Sep

AEGN

Aegion

$20.77

-0.46 (-2.17%)

13:03
09/18/19
09/18
13:03
09/18/19
13:03
Hot Stocks
Aegion unit awarded $9.3M contract from MWRD in Denver »

Aegion announced that its…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Sep

BYND

Beyond Meat

$157.51

-2.86 (-1.78%)

, QSR

Restaurant Brands

$73.77

-0.08 (-0.11%)

13:01
09/18/19
09/18
13:01
09/18/19
13:01
Periodicals
Tim Hortons to pull back on Beyond Meat offerings, Journal de Montreal says »

A translation of a French…

BYND

Beyond Meat

$157.51

-2.86 (-1.78%)

QSR

Restaurant Brands

$73.77

-0.08 (-0.11%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Nov

BX

Blackstone

$52.97

-0.53 (-0.99%)

13:01
09/18/19
09/18
13:01
09/18/19
13:01
Periodicals
Breaking Periodicals news story on Blackstone »

Blackstone near $2.9B…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Sep

  • 26

    Sep

RYAAY

Ryanair

$61.95

-0.14 (-0.23%)

12:53
09/18/19
09/18
12:53
09/18/19
12:53
Initiation
Ryanair initiated  »

Ryanair initiated with an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPX

S&P 500

$0.00

(0.00%)

, SPY

SPDR S&P 500 ETF Trust

$300.17

-0.77 (-0.26%)

12:47
09/18/19
09/18
12:47
09/18/19
12:47
Hot Stocks
Gundlach sees 'increasing probability' of recession before 2020 election »

Jeffrey Gundlach of…

SPX

S&P 500

$0.00

(0.00%)

SPY

SPDR S&P 500 ETF Trust

$300.17

-0.77 (-0.26%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GOOG

Alphabet

$1,228.87

-0.74 (-0.06%)

, GOOGL

Alphabet Class A

$1,228.96

-0.41 (-0.03%)

12:45
09/18/19
09/18
12:45
09/18/19
12:45
Hot Stocks
Google says YouTube Masthead coming to TV screen »

Google said in a blog…

GOOG

Alphabet

$1,228.87

-0.74 (-0.06%)

GOOGL

Alphabet Class A

$1,228.96

-0.41 (-0.03%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Sep

  • 24

    Sep

  • 27

    Oct

JPM

JPMorgan

$118.64

0.09 (0.08%)

12:45
09/18/19
09/18
12:45
09/18/19
12:45
Periodicals
JPMorgan's Dimon says his gut says a recession is 'not imminent,' CNBC reports »

JPMorgan Chairman and CEO…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

  • 15

    Oct

  • 27

    Oct

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.